Literature DB >> 25336678

Impact of retinopathy of prematurity on ocular structures and visual functions.

Alistair Fielder1, Hannah Blencowe2, Anna O'Connor3, Clare Gilbert4.   

Abstract

The preterm baby may develop ophthalmic sequelae which can be due to prematurity per se, due to retinopathy of prematurity (ROP) or due to neurological damage. Focusing on the former two, we discuss how in high-income countries the risk of sight-threatening ROP is largely confined to babies <1000 g birth weight (BW), whereas in low-income or middle-income countries babies exceeding 2500 g BW can be blinded. The effects of prematurity and ROP are presented as regional and global estimates of acute-phase ROP and the consequent mild/moderate and severe visual impairment. We discuss sequelae and how they affect the eye and its shape, strabismus and finally consider their impact on visual functions, including visual acuity, the visual field, colour vision and contrast sensitivity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Epidemiology; Neonatology; Ophthalmology; Outcomes research

Mesh:

Year:  2014        PMID: 25336678     DOI: 10.1136/archdischild-2014-306207

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  21 in total

1.  Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity.

Authors:  Kathleen A Kennedy; Helen A Mintz-Hittner
Journal:  J AAPOS       Date:  2017-12-06       Impact factor: 1.220

2.  Retinopathy of prematurity in Africa: a systematic review.

Authors:  Daniel Wang; Roseline Duke; Rv Paul Chan; J Peter Campbell
Journal:  Ophthalmic Epidemiol       Date:  2019-03-01       Impact factor: 1.648

Review 3.  The neural retina in retinopathy of prematurity.

Authors:  Ronald M Hansen; Anne Moskowitz; James D Akula; Anne B Fulton
Journal:  Prog Retin Eye Res       Date:  2016-09-23       Impact factor: 21.198

4.  Vascular changes on fluorescein angiography of premature infants with low risk of retinopathy of prematurity after high oxygen exposure.

Authors:  Maria Ana Martinez-Castellanos; Raul Velez-Montoya; Kenneth Price; Andree Henaine-Berra; Gerardo García-Aguirre; Virgilio Morales-Canton; Linda Alejandra Cernichiaro-Espinosa
Journal:  Int J Retina Vitreous       Date:  2017-01-16

5.  Following up children born preterm.

Authors:  P Vijayalakshmi; Clare Gilbert
Journal:  Community Eye Health       Date:  2017

6.  Effects of Early Intervention on Visual Function in Preterm Infants: A Randomized Controlled Trial.

Authors:  Camilla Fontana; Agnese De Carli; Daniela Ricci; Francesca Dessimone; Sofia Passera; Nicola Pesenti; Matteo Bonzini; Laura Bassi; Letizia Squarcina; Claudia Cinnante; Fabio Mosca; Monica Fumagalli
Journal:  Front Pediatr       Date:  2020-06-04       Impact factor: 3.418

7.  Dome-shaped macula in premature infants visualized by handheld spectral-domain optical coherence tomography.

Authors:  Alex T Legocki; Yasman Moshiri; Emily M Zepeda; Thomas B Gillette; Ayesha Shariff; Laura E Grant; Leona Ding; Aaron Y Lee; Cecilia S Lee; Kristina Tarczy-Hornoch; Michelle T Cabrera
Journal:  J AAPOS       Date:  2021-05-24       Impact factor: 1.325

8.  In Vivo Angiography Quantifies Oxygen-Induced Retinopathy Vascular Recovery.

Authors:  Olachi J Mezu-Ndubuisi
Journal:  Optom Vis Sci       Date:  2016-10       Impact factor: 1.973

9.  Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity.

Authors:  Savleen Kaur; Jaspreet Sukhija; Deeksha Katoch; Mansi Sharma; Ramanuj Samanta; Mangat R Dogra
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

10.  Study protocol for prognosis and treatment strategy of peripheral persistent avascular retina after intravitreal anti-VEGF therapy in retinopathy of prematurity.

Authors:  Ying Yu; Jianxun Wang; Feng Chen; Wensi Chen; Nan Jiang; Daoman Xiang
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.